Posts by date
June 2023 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Posts by title
-
Join 4,389 other subscribers
lung cancer resources
- About.com: Lung Cancer
- American Society of Clinical Oncology
- Bonnie J. Addario Lung Cancer Foundation
- Cancer Clinical Trials Blog
- Cure Today
- Global Resource for Advancing Cancer Education
- Lung Cancer Alliance
- Lung Cancer Online
- LUNGevityhttp://events.lungevity.org/site/PageServer
- National Lung Cancer Partnership
- Uniting Against Lung Cancer
- ABC World News advanced lung cancer Alimta ALK+ ALK+ lung cancer ALK + lung cancer ALK inhibitors ALK mutation Alk mutations ALK positive lung cancer Attitude attitude and cancer binimetinib Camp Kesem Cancer and our children carboplatin Carboplatin and Alimta CDMRP ceritinib chemotherapy clinical trials clinical trials lung cancer Cobra coronavirus COVID-19 Crizotinib CT scans Death and dying depression and cancer Diane Legg Dr. Alice Shaw DS-1062a Dying G1202R ICRF LDK 378 LDK378 living with lung cancer living with stage IV lung cancer living with terminal lung cancer Lorbrena lorlatinib lorlatinib and binimetinib lung cancer lung cancer advocacy Marfa Marfa Texas medical research Mortality mucositis NSCLC pandemic pemetrexed PF-02341066 PF-06463922 Pfizer phase I clinical trials positive attitude and cancer progression progression lung cancer Sarah Broom SHP2 and lorlatinib side effects of cancer treatment Stage IV cancer stage IV lung cancer targeted therapies terminal cancer terminal illness terminal illness and depression terminal lung cancer TNO155 plus lorlatinib TPX-0131 triage WageWorks Xalkori
Posts by subject
Search Results for: Don't call me partner
Don’t call me partner
Warning: this may be the most contentious blog I’ve ever written. That is because I am about to desecrate a sacred cow–the idea of patient as a partnerĀ in medical research. Lovely in notion, the reality is something quite different and … Continue reading
Sigh.
Just another way in which I am between a rock and a hard place. I need pharma. Obviously, they have also needed me. Or, at least, someone else with a similar genetic profile and the balls to join first in … Continue reading
Hitting that glass ceiling
I had to be in Boston bright and early yesterday morning for an echocardiogram. The technician noted that this was my 36th echo, and that she thought that was probably a record. Honey, don’t get me started. I’m in the … Continue reading
The financial toxicity that is part of staying alive
Cancer is big business. Yep, I said it. What is a devastation for us, as individuals, is an opportunity for others. I have sat in on meetings where that word opportunity was bandied about as if I, an opportunity myself, … Continue reading
Dear Pharma;
For all but one of the past seven years I have served as a peer reviewer for the CDMRP. It is perhaps the toughest form of advocacy that I have undertaken but also one of the most rewarding. I never … Continue reading
Posted in Clinical Trials
Tagged CDMRP, cellular damage CT scans, clinical trials, stage IV lung cancer
A Bear behind
I’ve been gone for awhile now and I feel a stranger in my own blog. I apologize for such an extended silence—I know that in this community the lack of an update is worrying. So let me start by saying … Continue reading
Tales from the hood
So what’s been going on here aside from swimming laps and the eating of greens? We had a lovely Fourth of July. After dropping Peter at a party, David and I picked up our dinner at a farm stand. I … Continue reading
Posted in Lifestyle, Living with lung cancer
Tagged cheeky teenagers, medical marijuana, stage IV lung cancer
Cancer is my day job
And sometimes I just have to call in sick. I take this blog seriously; so much so, that even though there is no time card to punch and no pay check at the end of the month, I really feel … Continue reading